EDAP TMS announced a scientific presentation demonstrating the technical feasibility of performing non-thermal histotripsy energy delivery using its Focal One Robotic HIFU technology. This early feasibility work was presented at the 187th Acoustical Society of America Meeting.
The results showed the Focal One system's ability to generate histotripsy lesions in biological tissues ex vivo. This marks an important step in expanding the company's ultrasound energy-based therapy platform.
This development indicates potential for new applications and treatment modalities for the Focal One system beyond its current thermal ablation capabilities. It highlights EDAP's ongoing commitment to innovation in therapeutic ultrasound.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.